Ipilimumab and radiation therapy for melanoma brain metastases

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

2008 • 25,031 citations

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

2010 • 14,016 citations

Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

2011 • 7,390 citations

Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma

2011 • 4,304 citations

Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria

2009 • 3,044 citations

Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma

2012 • 1,925 citations

An introduction to survival analysis using Stata

2003 • 1,917 citations

Importance of events per independent variable in proportional hazards regression analysis II. Accuracy and precision of regression estimates

1995 • 1,854 citations

Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti–CTLA-4 Antibody

2009 • 1,480 citations

Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial

2012 • 1,052 citations

Diagnosis-Specific Prognostic Factors, Indexes, and Treatment Outcomes for Patients With Newly Diagnosed Brain Metastases: A Multi-Institutional Analysis of 4,259 Patients

2009 • 936 citations

Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial

2012 • 885 citations

Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma

1998 • 548 citations

Determinants of Outcome in Melanoma Patients With Cerebral Metastases

2004 • 431 citations

The Abscopal Effect Associated With a Systemic Anti-melanoma Immune Response

2013 • 362 citations

Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival

2012 • 327 citations

Local Radiation Therapy Inhibits Tumor Growth through the Generation of Tumor-Specific CTL: Its Potentiation by Combination with Th1 Cell Therapy

2010 • 225 citations

Ipilimumab in melanoma with limited brain metastases treated with stereotactic radiosurgery

2013 • 176 citations

Determinants of survival in patients with brain metastases from cutaneous melanoma

2010 • 158 citations

Use of Magnetic Resonance Imaging to Assess Blood-Brain/Blood-Glioma Barrier Opening During Conformal Radiotherapy

2005 • 152 citations

Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma

2010 • 132 citations

The Tumor-Immune Microenvironment and Response to Radiation Therapy

2010 • 128 citations

GAMMA KNIFE RADIOSURGERY IN THE MANAGEMENT OF MALIGNANT MELANOMA BRAIN METASTASES

2007 • 117 citations

Safety and clinical activity of ipilimumab in melanoma patients with brain metastases

2011 • 110 citations

NK and CD4 Cells Collaborate to Protect against Melanoma Tumor Formation in the Brain

2006 • 61 citations

Radiation-induced tumor neoantigens: imaging and therapeutic implications.

2011 • 52 citations

Radiation necrosis of the brain in melanoma patients successfully treated with ipilimumab, three case studies

2012 • 52 citations

Pathologic and gene expression features of metastatic melanomas to the brain

2013 • 47 citations

Surgical management of melanoma brain metastases in patients treated with immunotherapy

2011 • 40 citations

Gamma knife radiosurgery for intracranial metastatic melanoma: a 6-year experience

2002 • 33 citations

Concurrent whole brain radiotherapy and bortezomib for brain metastasis

2013 • 15 citations